List of bibliographic references indexed by Antiparkinson Agents (adverse effects)
Number of relevant bibliographic references: 132.
[40-60] [
0 - 20][
0 - 50][
60-80]
Ident. | Authors (with country if any) | Title |
---|
001723 (2011) |
O. Rascol [France] | Drugs and drug delivery in PD: optimizing control of symptoms with pramipexole prolonged‐release |
001998 (2010) |
Santiago Perez Lloret [France] ; Olivier Rascol | Pramipexole extended-release (once-daily formulation) for the treatment of Parkinson's disease. |
001C04 (2010) |
Olivier Rascol [France] ; Paolo Barone [Italie] ; Robert A. Hauser [États-Unis] ; Yoshikuni Mizuno [Japon] ; Werner Poewe [Autriche] ; Anthony H. V. Schapira [Royaume-Uni] ; Laurence Salin [France] ; Mandy Sohr [Allemagne] ; Catherine Debieuvre [France] | Efficacy, safety, and tolerability of overnight switching from immediate‐ to once daily extended‐release pramipexole in early Parkinson's disease |
001C10 (2010) |
David Devos [France] ; L. Defebvre [France] ; R. Bordet [France] | Dopaminergic and non‐dopaminergic pharmacological hypotheses for gait disorders in Parkinson’s disease |
001E72 (2009) |
C. Ardouin [France] ; I. Chéreau ; P-M Llorca ; E. Lhommée ; F. Durif ; P. Pollak ; P. Krack | [Assessment of hyper- and hypodopaminergic behaviors in Parkinson's disease]. |
001E89 (2009) |
Olivier Rascol [France] ; Santiago Perez-Lloret | Rotigotine transdermal delivery for the treatment of Parkinson's disease. |
001E92 (2009) |
Clemence Simonin [France] ; M. Tir ; D. Devos ; A. Kreisler ; K. Dujardin ; J. Salleron ; A. Delval ; S. Blond ; L. Defebvre ; A. Destée ; P. Krystkowiak | Reduced levodopa-induced complications after 5 years of subthalamic stimulation in Parkinson's disease: a second honeymoon. |
001F21 (2009) |
Alain Destée [France] ; Karin Rérat ; Isabelle Bourdeix | Is there a difference between levodopa/ dopa-decarboxylase inhibitor and entacapone and levodopa/dopa-decarboxylase inhibitor dose fractionation strategies in Parkinson's disease patients experiencing symptom re-emergence due to wearing-off? The Honeymoon Study. |
001F36 (2009) |
Philippe Damier [France] | Drug-induced dyskinesias. |
002048 (2009) |
David Devos [France] | Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease |
002207 (2009) |
Joëlle Micallef [France] ; Marc Rey [France] ; Alexandre Eusebio [France] ; Christine Audebert [France] ; Frank Rouby [France] ; Elisabeth Jouve [France] ; Sophie Tardieu [France] ; Oliver Blin [France] | Antiparkinsonian drug-induced sleepiness: a double-blind placebo-controlled study of L-dopa, bromocriptine and pramipexole in healthy subjects |
002214 (2009) |
E. Lohmann [France] ; S. Thobois [France] ; S. Lesage [France] ; E. Broussolle [France] ; S. Tezenas Du Montcel [France] ; M.-J. Ribeiro [France] ; P. Remy [France] ; A. Pelissolo [France] ; B. Dubois [France] ; L. Mallet [France] ; P. Pollak [France] ; Yves Agid [France] ; A. Brice [France] | A multidisciplinary study of patients with early-onset PD with and without parkin mutations |
002292 (2008) |
Gilles Fénelon [France] | Psychosis in Parkinson's disease: phenomenology, frequency, risk factors, and current understanding of pathophysiologic mechanisms. |
002295 (2008) |
Agnès Nadjar [France] ; Charles R. Gerfen [États-Unis] ; Erwan Bezard [France] | Priming for L-dopa-induced dyskinesia in Parkinson’s disease: a feature inherent to the treatment or the disease? |
002545 (2008) |
Dominique Guehl [France] ; Pierre Burbaud [France] ; Christian Lorenzi [France] ; Christophe Ramos [France] ; Bernard Bioulac [France] ; Catherine Semal [France] ; Laurent Demany [France] | Auditory temporal processing in Parkinson's disease |
002824 (2007) |
Jean-Christophe Corvol [France] ; Jean-Baptiste Anzouan-Kacou [France] ; Elodie Fauveau [France] ; Anne-Marie Bonnet [France] ; Bénédicte Lebrun-Vignes [France] ; Camille Girault [France] ; Yves Agid [France] ; Philippe Lechat [France] ; Richard Isnard [France] ; Lucette Lacomblez [France] | Heart Valve Regurgitation, Pergolide Use, and Parkinson Disease : An Observational Study and Meta-analysis |
002A02 (2006) |
Olivier Rascol [France] ; David J. Brooks [Royaume-Uni] ; Amos D. Korczyn [Israël] ; Peter P. De Deyn [Belgique] ; Carl E. Clarke [Royaume-Uni] ; Anthony E. Lang [Canada] ; Mona Abdalla [Royaume-Uni] | Development of dyskinesias in a 5‐year trial of ropinirole and L‐dopa |
002A92 (2006) |
Jean-Pierre Wolf [France] ; Malika Bouhaddi [France] ; Francis Louisy [France] ; Andrei Mikehiev [France] ; Laurent Mourot [France] ; Sylvie Cappelle [France] ; Fabrice Vuillier [France] ; Pierre Andre [France] ; Lucien Rumbach [France] ; Jacques Regnard [France] | Side-effects of l-dopa on venous tone in Parkinson's disease : a leg-weighing assessment |
002B71 (2005) |
C. Guigoni [France] ; I. Aubert ; Q. Li ; V V Gurevich ; J L Benovic ; S. Ferry ; U. Mach ; H. Stark ; L. Leriche ; K. H Kansson ; Bernard H. Bioulac ; Christian E. Gross ; Pierre Sokoloff ; Gilberto Fisone ; E V Gurevich ; Bertrand Bloch ; Erwan Bezard | Pathogenesis of levodopa-induced dyskinesia: focus on D1 and D3 dopamine receptors. |
002B77 (2005) |
| Levodopa + carbidopa + entacapone. Entacapone: a second look: new preparations. Parkinson's disease: a modest effect. |
002B79 (2005) |
Isabelle Arnulf [France] | Excessive daytime sleepiness in parkinsonism. |
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i -k "Antiparkinson Agents (adverse effects)"
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/KwdEn.i \
-Sk "Antiparkinson Agents (adverse effects)" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= ParkinsonFranceV1
|flux= Main
|étape= Exploration
|type= indexItem
|index= KwdEn.i
|clé= Antiparkinson Agents (adverse effects)
}}
| This area was generated with Dilib version V0.6.29. Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024 | ![](Common/icons/LogoDilib.gif) |